期刊文献+

血清脂肪因子CXCL5水平与肥胖和胰岛素抵抗的相关性 被引量:1

Relationship of serum CXCL5 with obesity and insulin resistance
原文传递
导出
摘要 目的探讨脂肪因子CXCL5与肥胖、胰岛素抵抗的相关性。方法将86例血糖调节正常者按体重指数(BMI)分为男性超重或肥胖组(A组,26例,BMI≥25)、女性超重或肥胖组(B组,17例,BMI≥25)、男性正常体重组(C组,23例,BMI<25)和女性正常体重组(D组,20例,BMI<25)。ELISA法测定血清CXCL5水平。结果 D组血清CXCL5水平明显高于C组(P<0.01);B组血清CXCL5水平显著高于A组(P<0.01);A组血清CXCL5水平显著高于C组(P<0.05)。男性血清CXCL5水平与BMI、腰围(WC)、腰臀比(WHR)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)呈正相关(P<0.05),与胰岛素抵抗指数(HOMA-IR)无明显相关性。多元线性回归提示WC、LDL-C是男性组血清CXCL5水平的独立影响因素。结论 CXCL5可能参与肥胖和脂代谢紊乱病理生理过程。 Objective To investigate the relationship of serum CXCL5 with obesity and insulin resistance.Methods On the basis of body mass index(BMI),86 patients with normal glucose regulation were divided into four groups of A(obese male,26 cases,BMI≥25),B(obese female,17 cases,BMI≥25),C(lean male,23 cases,BMI25)and D(lean female,20 cases,BMI25).Serum CXCL5 was detected by ELISA.Results Serum CXCL5 concentrations were significantly higher in group D than those in group C(P0.01),which were higher in group B than those in group A(P0.01).Serum CXCL5 concentrations were significantly higher in group A than those in group C(P0.05).Serum CXCL5 levels in males were positively correlated with BMI,waist-hip ratio(WHR),total cholesterol(TC) and low density lipoprotein cholesterol(LDL-C)(P0.05),but not with HOMA-IR.Stepwise regression analysis showed that WC and LDL-C were the independent variables of CXCL5.Conclusion CXCL5 might play a role in the pathophysiology of obesity and lipid metabolism.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第9期1038-1040,共3页 Jiangsu Medical Journal
关键词 CXCL5 肥胖 胰岛素抵抗 CXCL5 Obesity Insulin resistance
  • 相关文献

参考文献8

  • 1Chavey C,Lazennec G,Lagarrigue S,et al. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance[J]. Cell Metab, 2009,9 (4) : 339-349.
  • 2Zhen Yang, Zhaoyun Zhang, Jie Wen, et al. Elevated serum chemokine CXC ligand 5 levels are associated with hyperchol esterolemia but not a worsening of insulin resistance in Chinese people[J]. J Clin Endocrinol Metab, 2010,95(8) : 3926-3932.
  • 3胡云,朱大龙,韩光晓,黄洪,顾经宇.不同糖耐量者血浆肿瘤坏死因子-α与游离脂肪酸及胰岛素抵抗的关系[J].江苏医药,2004,30(3):184-186. 被引量:4
  • 4Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance[J]. J Clin Invest, 2003,112(12) : 1821-1830.
  • 5Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue[J]. J Clin Invest, 2003,112(12) : 1796-1808.
  • 6Walz A,Schmutz P,Mueller C, et al. Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease[J]. J Leukoc Biol,1997,62(5):604-611.
  • 7Combs TP,Berg AH,Rajala MW,et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocytespecific secretory protein adiponectin[J]. Diabetes, 2003, 52 (2) : 268-276.
  • 8Sead MF,Damani S, Gingerich RL, et al. Sexual dimorphism in plasma leptin concentration[J]. J Clin Endocrinol Metab, 1997,82(2) : 579-584.

二级参考文献9

  • 1[1]Hotamisligil GS,Arner P,Cavo JF,et al.Increased adipose tissue expression of TNF-α in human obesity and insulin resistance.J Clin Invest,1995,95:2409-2415.
  • 2[2]Hotamisligil GS,Peraldi P,Budavari A,et al.IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in tumor necrosis factor-a and obesity-induced insulin resistance.Science,1996,271:665-668.
  • 3[3]Spiegelman B,Peraldi P.TNF-α and insulin resistance:Summary and future prospects.Mol and Cell Biochem,1998,182:169-175.
  • 4[4]Katsuki A,Sumida Y,Murashima S.Serum levels of tumor necrosis factor-a are Increased in obese patients with noninsulin-dependent diabetes mellitus.J Clin Endocr and Metab,1998,83:859-862.
  • 5[5]Zinman B,Hanley AJ,Harris SB,et al.Circulation tumor necrosis factor-α concentrations in a native Canadian Population with high rate of type 2 diabetes mellitus.J Clin Endo and Meta,1999,84:272-278.
  • 6[6]Smith U,Axelsen M,Carvalho E,et al.Insulin signaling and action in fat cells:associations with insulin resistance and type 2 diabetes.Ann N Y Acad Sci,1999,18;892:119-126.
  • 7[7]Hotamisligil GS,Budavari A,Murray D,et al.Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes.Central role of tumor necrosis factor-alpha.J Clin Invest,1994,4:1543-1549.
  • 8[8]Boden G.Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.Diabetes,1997,46:3-10.
  • 9[9]Reynisdottir S,Angelin B,Langin D,et al.Adipose tissue lipoprotein lipase and hormone-sensitive lipase.Coutrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.Arter Thro Vasc Biol,1997,17:2287-2292.

共引文献3

同被引文献7

  • 1Waki H, Tontonoz P. Endocrine function of adipose tissue[ J]. An- nu Rev Pathol, 2007,2(2) :31-56.
  • 2Chavey C, Lazennec G, Lagarrigue S, et al. CXC ligand 5 is an ad- iposetissue derived factor that links obesity to insulin resistance [ J ]. Cell Metab, 2009,9(4) :339-349.
  • 3Chavey C, Fajas L. CXCL5 drives obesity to diabetes, and further [J]. Aging July, 2009,1 (7) :674-677.
  • 4Zhen Y, Zhaoyun Z, Jie W, et al. Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in chinese people[ J]. J Clin Endo- crinol Metab, 2010,95 ( 8 ) :3926-3932.
  • 5Qatanani M, Lazar MA. Mechanisms of obesityassociated insulin re- sistance: many choices on the menu [J]. Genes Dev, 2007,21 (12) : 1443-1455.
  • 6Walz A, Schmutz P, Mueller C, et al. Regulation and function of the CXC chemokine ENA278 in monocytes and it srole in disease [J]. J LeukoC Biol, 1997,62(5) :604-611.
  • 7Chen L, Yang Z, Lu B, et al. Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes [ J ]. Glin Endocri- nol, 2011,75 (6) :766-770.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部